Publications by authors named "Merve Atli"

Claim this Profile
T
The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.
Namik Kirlić, Merve Atli, Sunil Mistry, Michael Gold, Guy M Goodwin

J Clin Psychopharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
Robert F Dougherty, Patrick Clarke, Merve Atli, Joanna Kuc, Danielle Schlosser

Psychopharmacology (Berl)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
Guy M Goodwin, Ania Nowakowska, Merve Atli, Boadie W Dunlop, David Feifel

J Clin Psychiatry· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.
Namik Kirlić, Molly Lennard-Jones, Merve Atli, Ekaterina Malievskaia, Nadav L Modlin

Am J Psychiatry· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, Merve Atli, James C Bennett

J Affect Disord· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis